IRVINE, CA--(Marketwire - August 11, 2011) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the World’s leading dental laser manufacturer and distributor, today announced that it has named veteran regulatory affairs executive Ehab M. Esmail its Vice President of Global Regulatory, Quality and Clinical Affairs, effective August 9, 2011. Esmail will report directly to Chairman and CEO Federico Pignatelli.
Esmail, 39, has more than 18 years of diversified experience working as a specialist in regulatory affairs in the medical device and biologics industries. During that time, he has been proactive in managing product registrations, averaging more than 340 annually over the last five years plus clinical studies and reacting to changes in government regulations as they relate to existing products and the development of new products.
Prior to coming to BIOLASE, Esmail for the past 11 years has held positions of increasing responsibility at Arlington, TN-based Wright Medical Technology, Inc., a publicly-traded global medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. For the past two years, he was Senior Director, Regulatory Affairs and led Wright Medical’s interaction with regulatory authorities in a variety of countries including the U.S., Canada, Australia, Brazil, France and Germany.
Federico Pignatelli, Chairman and CEO, said, “Ehab has a strong background in regulatory affairs and a proven track record of achieving results at a global, publicly-traded medical device company. He has also shown expertise for obtaining medical device registration under different global regulatory environments, including the emerging markets in Asia, Eastern Europe, the Middle East and Latin America, and especially Brazil where he established Wright Medical Brazil for direct Regulatory Registration to ANVISA, all of which are very important to BIOLASE as we develop and roll out our array of upcoming new products. His 18 years of related experience and his position on the Board of Directors of the Orthopedic Surgical Manufacturers Association (OSMA) since 2009 will also prove invaluable to us as we expand into the orthopedics market with our core Er,Cr:YSGG laser technology. We look forward to working with Ehab at this exciting time for BIOLASE.”
Prior to working at Wright Medical, Esmail spent seven years at UK-based Smith & Nephew, Inc.'s Orthopedic Division. During the last two years at Smith & Nephew, Esmail was Senior Regulatory/Clinical Affairs Specialist and managed all product registrations and clinical studies, among other responsibilities.
Esmail has a bachelor of science degree in mechanical engineering from the University of Memphis. He is also a graduate of the Executive Development Program for Senior Regulatory Professionals at Northwestern University’s Kellogg School of Management.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World’s leading Dental Laser company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company’s laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets.
For updates and information on laser and Waterlase dentistry, find BIOLASE at http://www.biolase.com, Twitter at http://twitter.com/GoWaterlase, and YouTube at http://www.youtube.com/user/Rossca08.
Certain statements in this release concerning the Biolase Technology, Inc. and its prospects and future growth are forward-looking and involved a number of uncertainties and risks. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to, the performance of the global economy and the growth in dental laser sales, dental imaging equipments and other products that we manufacture and/or distribute that are focused on technologies that advance the practice of dentistry and medicine; market acceptance of the Company’s products and services; customer and industry analyst perception of the company and its technology vision and future prospects; the success of certain business combinations engaged in by the Company or by competitors; political unrest or acts of war; possible disruptive effects of organizational or personnel changes; and other factors described in Biolase Technology, Inc.'s periodic reports filed with the U.S. Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2010 and its quarterly report on Form 10-Q for the three and six-month periods ended June 30, 2011. Such information is subject to change, and we undertake no obligation to update such statements.
For further information, please contact:
Jill Bertotti
Allen & Caron
+1-949-474-4300
